Amphastar Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Amphastar Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2014 to Q3 2024.
  • Amphastar Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $5.6M, a 20.5% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $23.4M, a 17.2% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $20.2M, a 13.3% increase from 2022.
  • Amphastar Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $17.9M, a 4.43% decline from 2021.
  • Amphastar Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $18.7M, a 8.84% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $23.4M $5.6M +$952K +20.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $22.4M $5.78M +$915K +18.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $21.5M $7.36M +$1.25M +20.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $20.2M $4.62M +$318K +7.39% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $19.9M $4.64M +$345K +8.03% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $19.6M $4.87M +$630K +14.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $18.9M $6.11M +$1.09M +21.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $17.9M $4.3M +$454K +11.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $17.4M $4.3M +$380K +9.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $17M $4.24M -$1.85M -30.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $18.9M $5.02M +$188K +3.89% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $18.7M $3.85M -$483K -11.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $19.2M $3.92M -$451K -10.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $19.6M $6.08M -$429K -6.59% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $20.1M $4.83M -$448K -8.48% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $20.5M $4.33M +$38K +0.89% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $20.5M $4.37M +$76K +1.77% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $20.4M $6.51M +$2.48M +61.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $17.9M $5.28M +$608K +13% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $17.3M $4.3M +$385K +9.85% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-11
Q3 2019 $16.9M $4.29M +$386K +9.88% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $16.5M $4.03M -$164K -3.91% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $16.7M $4.67M +$8K +0.17% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $16.7M $3.91M -$272K -6.5% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-15
Q3 2018 $17M $3.91M -$248K -5.97% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $17.2M $4.2M -$102K -2.37% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $17.3M $4.67M +$215K +4.83% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $17.1M $4.18M +$662K +18.8% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-16
Q3 2017 $16.4M $4.16M +$601K +16.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $15.8M $4.3M +$100K +2.38% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $15.7M $4.45M +$600K +15.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $15.1M $3.52M +$62K +1.79% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-15
Q3 2016 $15.1M $3.56M +$128K +3.74% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $14.9M $4.2M +$498K +13.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $14.4M $3.85M +$1.62M +72.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $12.8M $3.46M +$859K +33.1% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-14
Q3 2015 $12M $3.43M +$767K +28.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $11.2M $3.7M +$1.3M +53.8% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $9.89M $2.23M +$614K +38% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $9.28M $2.6M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 $2.66M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 $2.41M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $1.62M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.